Citi sets a USD 500.00 target for Intuitive Surgical stock

Published on 10/06/2026 at 13:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached USD 2.89 billion in the second quarter of 2026. Intuitive Surgical stock stands at EUR 362.00 versus EUR 362.08 on October 6, 2026.

Aquarellillustration mit laparoskopischen Instrumenten in einem leuchtenden transluzenten Körperumriss, weiche Türkis- und Koralltöne, zarte Tuschelinien, medizinische Illustrationsästhetik auf weißem Papier — Intuitive Surgical US46120E6023 Aquarell minimal-invasive Chirurgie mit transparenter Körpersilhouette in weichen Türkis-Farbtönen, Illustration mit AI erstellt.

Intuitive Surgical (ISIN US46120E6023) was trading at EUR 362.00 at Lang & Schwarz on October 6, 2026 at 1:37 p.m. CEST, just below its EUR 362.08 prior close. The latest analyst action came from Citi on October 5, 2026, when Joanne Wuensch maintained a Buy rating and set a USD 500.00 price target, according to Markets Insider.

Citi target puts valuation in view

The USD 500.00 target is materially above the euro reference price, but the currencies represent separate markets and are not directly comparable. Citi's action therefore adds a fresh analyst signal without changing the Lang & Schwarz reference price used by German investors.

MarketBeat lists a consensus price target of USD 508.68 and a Moderate Buy rating, based on 22 Buy ratings, eight Holds and one Sell as of October 5, 2026. The breadth of coverage gives the target context, while the different target levels show that analysts do not share one uniform valuation view, according to MarketBeat.

Second-quarter revenue reached USD 2.89 billion

Intuitive Surgical reported USD 2.89 billion in revenue for the second quarter ended June 30, 2026, compared with USD 2.44 billion in the year-earlier quarter. That equals 18.40 percent year-over-year growth and gives the analyst targets an operating figure to assess, according to Markets Insider.

The company describes the da Vinci Surgical System as its flagship platform for robotic-assisted, minimally invasive surgery. Its investor site also identifies Intuitive Surgical as a Nasdaq-listed company, while the broader product portfolio includes the Ion system, instruments, accessories, digital technologies and service programs.

EUR quote holds near prior close

The Lang & Schwarz quote stood at EUR 362.00 on October 6, 2026 at 1:37 p.m. CEST, down minus 0.02 percent versus the EUR 362.08 prior close dated October 5, 2026. Separately, the Nasdaq quote was last at USD 406.48 at 4:00 p.m. ET on October 5, 2026, with market capitalization of USD 143.6 billion on that date.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.